Somatic gene mutations and their association with treatment outcomes among Indo-Asian Lung Cancer patients
This retrospective study highlights the molecular heterogeneity among lung cancer patients with EGFR and P53 being most frequent. While targeted therapies improved outcomes in mutation-positive patients, KRAS mutations correlated with resistance. Broader access to molecular testing and targeted treatments is essential for optimizing care in resource-limited settings.
Authors
- Pradeep Narayan (ORCID: https://orcid.org/0009-0005-8984-4473)
- Anuja Pradhan
- Safeena Kulsum
- Shaesta Naseem Zaidi
- Pragnya Coca
Institutions
- Narayana Health (IN)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.ctarc.2025.101039
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00